Ruta Rao to Follow-Up Studies
This is a "connection" page, showing publications Ruta Rao has written about Follow-Up Studies.
Connection Strength
0.061
-
Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group. Med Oncol. 2011 Dec; 28 Suppl 1:S39-47.
Score: 0.061